Evercore ISI Group Maintains Outperform on Zimmer Biomet Holdings, Lowers Price Target to $110

Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and lowers the price target from $120 to $110.